Prof. Dr. Warsito P. Taruno – Indonesian Scientist and Medical Physics Innovator
Prof. Dr. Warsito P. Taruno is a renowned Indonesian scientist and engineer best known for his groundbreaking work in medical physics, particularly the development of Electro-Capacitive Cancer Therapy (ECCT) – a non-invasive cancer treatment technology.
Early Life and Education:
Warsito was born in Indonesia and pursued his higher education in Japan. He earned his Ph.D. in engineering from Shizuoka University, where he specialized in Electrical Capacitance Volume Tomography (ECVT), a technique for visualizing three-dimensional images using capacitive sensors.
Scientific Contributions:
Originally developed for industrial applications, ECVT was later adapted by Warsito for medical use. He founded C-Tech Labs Edwar Technology, a research and development center focused on translating ECVT and ECCT into practical health applications.
In 2010, inspired by his sister's battle with cancer, Warsito developed the ECCT therapy vest, a wearable device that uses low-frequency, low-intensity electrical fields to inhibit the growth and spread of cancer cells. The therapy is non-invasive and designed to avoid damaging healthy tissue, unlike conventional methods such as chemotherapy or radiation.
Achievements and Recognition:
Founder of C-Tech Labs – a leading Indonesian R&D institute focused on applied physics and engineering innovation.
Developer of ECCT, a unique method claimed to suppress cancer growth through electro-capacitive fields.
Gained national and international attention for offering alternative cancer treatment, especially for underserved communities.
Controversies and Challenges:
Although many cancer patients reported improvements, the ECCT method has faced skepticism from parts of the medical community due to the lack of large-scale, peer-reviewed clinical trials. Indonesian health authorities, such as BPOM and the Ministry of Health, have urged further scientific validation before widespread medical endorsement.
Despite these hurdles, Prof. Warsito continues to advocate for scientific independence and innovation in Indonesia. His mission is to provide affordable, accessible cancer therapy to all, driven by empathy, science, and national pride.
Legacy and Impact:
Prof. Warsito’s work has inspired many young scientists in Indonesia and other developing countries to pursue practical, humanitarian applications of science. He stands as a symbol of how science, when driven by compassion, can become a tool of hope.
Founder of C-Tech Labs – a leading Indonesian R&D institute focused on applied physics and engineering innovation.
Developer of ECCT, a unique method claimed to suppress cancer growth through electro-capacitive fields.
Gained national and international attention for offering alternative cancer treatment, especially for underserved communities.
Controversies and Challenges:
Although many cancer patients reported improvements, the ECCT method has faced skepticism from parts of the medical community due to the lack of large-scale, peer-reviewed clinical trials. Indonesian health authorities, such as BPOM and the Ministry of Health, have urged further scientific validation before widespread medical endorsement.
Despite these hurdles, Prof. Warsito continues to advocate for scientific independence and innovation in Indonesia. His mission is to provide affordable, accessible cancer therapy to all, driven by empathy, science, and national pride.
Legacy and Impact:
Prof. Warsito’s work has inspired many young scientists in Indonesia and other developing countries to pursue practical, humanitarian applications of science. He stands as a symbol of how science, when driven by compassion, can become a tool of hope.
Comments
Post a Comment